Lutein treatment downregulates the expression of vascular endothelial growth factor while concurrently augmenting the levels of antioxidant enzymes for age-related macular degeneration autism spectrum disorder -like retinal degeneration, as well as the streptozotocin-induced diabetic retinopathy in mouse model [21]. The gene discussed is VEGFA; the disease is age-related macular degeneration.